Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.
Over the last 12 months, insiders at Illumina, Inc. have bought $991,672 and sold $214,105 worth of Illumina, Inc. stock.
On average, over the past 5 years, insiders at Illumina, Inc. have bought $991,672 and sold $21.97M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Thaysen Jacob (Chief Executive Officer) — $1.98M.
The last purchase of 7,330 shares for transaction amount of $991,672 was made by Thaysen Jacob (Chief Executive Officer) on 2024‑02‑22.
2024-02-22 | Thaysen Jacob | Chief Executive Officer | 7,330 0.0046% | $135.29 | $991,672 | -10.66% | ||
2023-11-07 | Sale | Hoyt Aimee L | SVP, Chief People Officer | 315 0.0002% | $112.84 | $35,545 | +11.28% | |
2023-08-22 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $167.04 | $83,520 | -19.95% | |
2023-07-24 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $190.08 | $95,040 | -29.44% | |
2023-06-22 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $200.00 | $100,000 | -33.81% | |
2023-05-22 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 5,000 0.0032% | $208.59 | $1.04M | -34.05% | |
2023-03-01 | Sale | Hoyt Aimee L | SVP, Chief People Officer | 3,917 0.0025% | $199.06 | $779,737 | -19.52% | |
2023-02-22 | Sale | Aravanis Alexander | SVP, Chief Technology Officer | 5,398 0.0034% | $201.74 | $1.09M | -17.67% | |
2023-02-06 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $211.57 | $105,785 | -12.16% | |
2023-01-09 | Sale | Hoyt Aimee L | SVP, Chief People Officer | 871 0.0005% | $205.57 | $179,051 | -9.26% | |
2023-01-06 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $204.58 | $102,290 | -6.35% | |
2022-12-06 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $212.63 | $106,315 | -5.57% | |
2022-11-08 | Sale | Aravanis Alexander | SVP, Chief Technology Officer | 361 0.0002% | $218.00 | $78,698 | -8.48% | |
2022-11-07 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $223.65 | $111,825 | -8.07% | |
2022-11-07 | Sale | Hoyt Aimee L | SVP, Chief People Officer | 1,045 0.0007% | $223.65 | $233,714 | -8.07% | |
2022-10-06 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 500 0.0003% | $216.59 | $108,295 | -4.75% | |
2022-07-05 | Sale | Aravanis Alexander | SVP, Chief Technology Officer | 539 0.0004% | $200.00 | $107,800 | +7.40% | |
2022-06-10 | Sale | TOUSI SUSAN H | SVP, Chief Commercial Officer | 250 0.0002% | $214.85 | $53,713 | +1.44% | |
2022-04-28 | Sale | Dadswell Charles | SVP & General Counsel | 368 0.0002% | $300.13 | $110,448 | -30.39% | |
2022-04-12 | Sale | Hoyt Aimee L | SVP, Chief People Officer | 100 <0.0001% | $355.38 | $35,538 | -38.64% |
TOUSI SUSAN H | SVP, Chief Commercial Officer | 45524 0.0287% | $105.68 | 0 | 42 | |
Thaysen Jacob | Chief Executive Officer | 14861 0.0094% | $105.68 | 1 | 0 | |
Hoyt Aimee L | SVP, Chief People Officer | 8314 0.0052% | $105.68 | 0 | 18 | |
WALT DAVID R | director | 631840 0.3979% | $105.68 | 0 | 217 | |
STUELPNAGEL JOHN R | Sr VP and COO | 337836 0.2127% | $105.68 | 0 | 22 | |
FLATLEY JAY T | director | 148933 0.0938% | $105.68 | 0 | 298 | |
West John | Sr. VP & GM DNA Sequencing | 82062 0.0517% | $105.68 | 0 | 10 | |
Ronaghi Mostafa | SVP, Entrepreneurial Devlopmt | 80162 0.0505% | $105.68 | 0 | 33 | |
Bianchi Paul L | Sr. VP, Human Resources | 65660 0.0413% | $105.68 | 0 | 13 | |
deSouza Francis A | President and CEO | 52603 0.0331% | $105.68 | 0 | 29 | |
ORPIN TRISTAN | Sr VP & Chief Commercial Offic | 45961 0.0289% | $105.68 | 0 | 102 | |
Cabou Christian | Sr VP & General Counsel | 45553 0.0287% | $105.68 | 0 | 41 | |
Lewis Mark L | Sr VP & General Manager | 44837 0.0282% | $105.68 | 0 | 6 | |
Posard Matthew L. | Sr VP & General Manager | 30858 0.0194% | $105.68 | 0 | 2 | |
Naclerio Nicholas | Sr VP, Corporate Development | 30020 0.0189% | $105.68 | 0 | 34 | |
Heath Gregory | Sr VP & General Manager | 26740 0.0168% | $105.68 | 0 | 19 | |
Klausner Richard | Sr VP, Chief Medical Officer | 23100 0.0145% | $105.68 | 0 | 3 | |
HENRY CHRISTIAN O | EVP & Chief Commercial Officer | 18976 0.0119% | $105.68 | 0 | 93 | |
Van Oene Mark | SVP Chief Commercial Officer | 17648 0.0111% | $105.68 | 0 | 19 | |
MOELLER GERALD | director | 17544 0.011% | $105.68 | 1 | 5 | +43.15% |
OSTADAN OMEAD | SVP Mktg, Prod & Strat Plan | 17172 0.0108% | $105.68 | 0 | 33 | |
BOWMAN A BLAINE | director | 16868 0.0106% | $105.68 | 11 | 36 | <0.0001% |
BRADBURY DANIEL | director | 15324 0.0096% | $105.68 | 0 | 67 | |
EASTHAM KARIN | director | 10838 0.0068% | $105.68 | 0 | 20 | |
Bouchard Michel | Chief Accounting Officer | 10387 0.0065% | $105.68 | 0 | 39 | |
ARNOLD FRANCES | director | 9954 0.0063% | $105.68 | 0 | 5 | |
DORSA CAROLINE | director | 8501 0.0054% | $105.68 | 0 | 1 | |
Dadswell Charles | SVP & General Counsel | 7427 0.0047% | $105.68 | 0 | 75 | |
McComb Joel | Sr VP & General Manager | 6984 0.0044% | $105.68 | 0 | 1 | |
Stapley Marc | EVP Strategy & Corp Developmt | 6957 0.0044% | $105.68 | 0 | 41 | |
RASTETTER WILLIAM H | director | 5953 0.0037% | $105.68 | 0 | 11 | |
Febbo Phillip G. | SVP Chief Medical Officer | 5774 0.0036% | $105.68 | 0 | 6 | |
GRINT PAUL C | director | 4200 0.0026% | $105.68 | 0 | 3 | |
RAGUSA ROBERT P | SVP, Global Quality & Ops | 4092 0.0026% | $105.68 | 0 | 6 | |
SAMAD SAM | SVP and CFO | 3879 0.0024% | $105.68 | 0 | 7 | |
EPSTEIN ROBERT S | director | 3256 0.0021% | $105.68 | 0 | 28 | |
GOLDSTEIN JACK | director | 3200 0.002% | $105.68 | 0 | 3 | |
WHITFIELD ROY A | director | 2853 0.0018% | $105.68 | 0 | 24 | |
Aravanis Alexander | SVP, Chief Technology Officer | 2922 0.0018% | $105.68 | 0 | 9 | |
MCGINNIS KAREN K | VP, Chief Accounting Officer | 1538 0.001% | $105.68 | 0 | 5 |
The Vanguard Group | $2.51B | 11.45 | 18.25M | +0.37% | +$9.14M | 0.05 | |
BlackRock | $1.9B | 8.67 | 13.81M | +3.82% | +$69.77M | 0.04 | |
State Street | $935.46M | 4.28 | 6.81M | +1.32% | +$12.18M | 0.04 | |
Edgewood Management | $913.97M | 4.18 | 6.66M | -3.24% | -$30.59M | 2.46 | |
Baillie Gifford Co | $787.72M | 3.6 | 5.74M | +8.73% | +$63.26M | 0.61 | |
Loomis, Sayles & Company | $605.89M | 2.77 | 4.41M | -0.28% | -$1.7M | 0.88 | |
Geode Capital Management | $513.58M | 2.35 | 3.75M | +3.16% | +$15.74M | 0.05 | |
Janus Henderson | $505.97M | 2.31 | 3.68M | -16.3% | -$98.57M | 0.28 | |
Morgan Stanley | $495.45M | 2.27 | 3.61M | -2.44% | -$12.39M | 0.04 | |
WCM Investment Management | $463.76M | 2.12 | 3.38M | +2,232.29% | +$443.88M | 1.1 | |
BNY Mellon | $389.37M | 1.78 | 2.84M | -2.5% | -$9.97M | 0.07 | |
Capital World Investors | $378.11M | 1.73 | 2.75M | +41.08% | +$110.11M | 0.06 | |
AllianceBernstein | $365.08M | 1.67 | 2.66M | -0.93% | -$3.42M | 0.13 | |
Wellington Management Company | $361.83M | 1.65 | 2.63M | -18.65% | -$82.95M | 0.06 | |
Invesco | $340.25M | 1.56 | 2.48M | -5.02% | -$18M | 0.07 | |
GuardCap Asset Management Limited | $284.1M | 1.3 | 2.07M | +1.08% | +$3.03M | 3.48 | |
Nuveen | $265.83M | 1.22 | 1.94M | +17.13% | +$38.87M | 0.08 | |
Bank of America | $255.92M | 1.17 | 1.86M | +23.08% | +$47.99M | 0.03 | |
Amundi | $176.52M | 0.95 | 1.51M | +0.5% | +$871,790.99 | 0.07 | |
Northern Trust | $190.94M | 0.87 | 1.39M | -3.1% | -$6.12M | 0.03 | |
Legal & General | $173.15M | 0.79 | 1.26M | -15.43% | -$31.59M | 0.04 | |
JPMorgan Chase | $155.81M | 0.71 | 1.13M | +77.62% | +$68.09M | 0.01 | |
Citadel Advisors LLC | $155.64M | 0.71 | 1.13M | +165.65% | +$97.05M | 0.1 | |
Select Equity Group, L.P. | $151.76M | 0.69 | 1.11M | -25.81% | -$52.78M | 0.55 | |
Corvex Management LP | $137.98M | 0.63 | 1M | +37.63% | +$37.73M | 7.01 | |
Charles Schwab | $131.06M | 0.6 | 954,422 | +3.16% | +$4.01M | 0.03 | |
Ubs Asset Management Americas Inc | $123.58M | 0.57 | 899,961 | -1.13% | -$1.41M | 0.04 | |
Goldman Sachs | $113.89M | 0.52 | 829,341 | -0.02% | -$23,756.35 | 0.02 | |
Senvest Management Llc | $107.43M | 0.49 | 782,307 | +19.22% | +$17.32M | 4.16 | |
Barclays | $106.48M | 0.49 | 775,416 | -26.32% | -$38.03M | 0.05 | |
Renaissance Technologies | $104.02M | 0.48 | 757,518 | +50.83% | +$35.06M | 0.17 | |
Ownership Capital | $103.43M | 0.47 | 753,198 | -7.44% | -$8.31M | 2.37 | |
Martin Currie Limited | $103.49M | 0.47 | 753,668 | +0.23% | +$241,133.92 | 3.18 | |
Findlay Park Partners LLP | $100.12M | 0.46 | 729,100 | New | +$100.12M | 0.92 | |
SoMa Equity Partners LP | $99.87M | 0.46 | 727,274 | -14.6% | -$17.07M | 5.85 | |
Deutsche Bank | $91.79M | 0.42 | 668,443 | +21.82% | +$16.44M | 0.04 | |
Voloridge Investment Management, LLC | $88.28M | 0.4 | 642,852 | -29.77% | -$37.42M | 0.2 | |
Credit Suisse | $87.8M | 0.4 | 639,413 | +4.09% | +$3.45M | 0.08 | |
Liontrust Investment Partners LLP | $79.97M | 0.37 | 582,388 | -3.13% | -$2.58M | 1.14 | |
Teacher Retirement System of Texas | $74.97M | 0.34 | 545,973 | +296.38% | +$56.06M | 0.48 | |
First Trust | $74.19M | 0.34 | 540,246 | -9.93% | -$8.18M | 0.08 | |
Chevy Chase Trust Holdings Inc | $72.57M | 0.33 | 528,466 | +12.03% | +$7.79M | 0.24 | |
Two Sigma | $69.63M | 0.32 | 507,039 | -4.8% | -$3.51M | 0.12 | |
Ameriprise Financial | $68.49M | 0.31 | 498,754 | -19.25% | -$16.32M | 0.02 | |
Jacobs Levy Equity Management | $68.29M | 0.31 | 497,274 | +19.57% | +$11.17M | 0.31 | |
Swiss National Bank | $65.3M | 0.3 | 475,500 | -3.94% | -$2.68M | 0.05 | |
Macquarie Group | $15.7B | 0.3 | 473,972 | +328.12% | +$12.03B | 12.76 | |
Df Dent Co Inc | $64.55M | 0.3 | 470,048 | -19.55% | -$15.69M | 0.79 | |
Avidity Partners Management Lp | $63.73M | 0.29 | 464,100 | New | +$63.73M | 2.31 | |
Fidelity Investments | $63.03M | 0.29 | 459,012 | +30.47% | +$14.72M | <0.01 |